Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients
Introduction and objectives: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Some dietary fatty acids have showed different bioactive functions in metabolic syndrome. The aim of this study is to determine the dietary consumption patterns and serum percent...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268120300697 |
id |
doaj-060751f447be41a2af70764d455fe01a |
---|---|
record_format |
Article |
spelling |
doaj-060751f447be41a2af70764d455fe01a2021-06-09T05:56:54ZengElsevierAnnals of Hepatology1665-26812020-09-01195482488Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patientsFabiola López-Bautista0Varenka J. Barbero-Becerra1María Yolanda Ríos2M. Ángeles Ramírez-Cisneros3Cristell A. Sánchez-Pérez4Martha H. Ramos-Ostos5Misael Uribe6Norberto C. Chávez-Tapia7Eva Juárez-Hernández8Molecular Biology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoTranslational Research Unit, Medica Sur Clinic and Foundation, Mexico City, MexicoChemical Research Center, IICBA, UAEM, Morelos, MexicoChemical Research Center, IICBA, UAEM, Morelos, MexicoTranslational Research Unit, Medica Sur Clinic and Foundation, Mexico City, MexicoIntegral Diagnosis and Treatment Center, Medica Sur Clinic and Foundation, Mexico City, MexicoGastroenterology and Obesity Department, Medica Sur Clinic and Foundation, Mexico City, MexicoTranslational Research Unit, Medica Sur Clinic and Foundation, Mexico City, MexicoTranslational Research Unit, Medica Sur Clinic and Foundation, Mexico City, Mexico; Corresponding author.Introduction and objectives: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Some dietary fatty acids have showed different bioactive functions in metabolic syndrome. The aim of this study is to determine the dietary consumption patterns and serum percentage of bioactive fatty acids in NAFLD patients. Patients and methods: Cross-sectional study with NAFLD patients and non-NAFLD patients. Dietary consumption of bioactive fatty acids was assessed by a food frequency questionnaire. NAFLD and liver fibrosis were diagnosed by transient elastography. The identification of serum bioactive fatty acids was achieved by gas chromatography–mass spectrometry (%). Bioactive fatty acids consumption was correlated with NAFLD clinical characteristics with the Spearman correlation analysis. Results: A total of 299 patients were included, whose mean of age and body mass index were 44.2 ± 9.9 years and 25.9 ± 3.8 kg/m2, respectively. The consumption of bioactive fatty acids was no different regarding the presence of NAFLD; however, the consumption of stearic and linoleic fatty acids was higher in relation with NAFLD severity (p ≤ 0.05). The consumption of myristic acid was higher in patients with fibrosis (p = 0.02). Serum percentage and dietary consumption did not show correlations. Conclusion: Dietary consumption of bioactive fatty acids is different according to NAFLD severity. Individualized diets according to NAFLD severity could be successful in order to prevent liver injury-related outcomes.http://www.sciencedirect.com/science/article/pii/S1665268120300697Body mass indexLipidsLiverNutritionNAFLD |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fabiola López-Bautista Varenka J. Barbero-Becerra María Yolanda Ríos M. Ángeles Ramírez-Cisneros Cristell A. Sánchez-Pérez Martha H. Ramos-Ostos Misael Uribe Norberto C. Chávez-Tapia Eva Juárez-Hernández |
spellingShingle |
Fabiola López-Bautista Varenka J. Barbero-Becerra María Yolanda Ríos M. Ángeles Ramírez-Cisneros Cristell A. Sánchez-Pérez Martha H. Ramos-Ostos Misael Uribe Norberto C. Chávez-Tapia Eva Juárez-Hernández Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients Annals of Hepatology Body mass index Lipids Liver Nutrition NAFLD |
author_facet |
Fabiola López-Bautista Varenka J. Barbero-Becerra María Yolanda Ríos M. Ángeles Ramírez-Cisneros Cristell A. Sánchez-Pérez Martha H. Ramos-Ostos Misael Uribe Norberto C. Chávez-Tapia Eva Juárez-Hernández |
author_sort |
Fabiola López-Bautista |
title |
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients |
title_short |
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients |
title_full |
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients |
title_fullStr |
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients |
title_full_unstemmed |
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients |
title_sort |
dietary consumption and serum pattern of bioactive fatty acids in nafld patients |
publisher |
Elsevier |
series |
Annals of Hepatology |
issn |
1665-2681 |
publishDate |
2020-09-01 |
description |
Introduction and objectives: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Some dietary fatty acids have showed different bioactive functions in metabolic syndrome. The aim of this study is to determine the dietary consumption patterns and serum percentage of bioactive fatty acids in NAFLD patients. Patients and methods: Cross-sectional study with NAFLD patients and non-NAFLD patients. Dietary consumption of bioactive fatty acids was assessed by a food frequency questionnaire. NAFLD and liver fibrosis were diagnosed by transient elastography. The identification of serum bioactive fatty acids was achieved by gas chromatography–mass spectrometry (%). Bioactive fatty acids consumption was correlated with NAFLD clinical characteristics with the Spearman correlation analysis. Results: A total of 299 patients were included, whose mean of age and body mass index were 44.2 ± 9.9 years and 25.9 ± 3.8 kg/m2, respectively. The consumption of bioactive fatty acids was no different regarding the presence of NAFLD; however, the consumption of stearic and linoleic fatty acids was higher in relation with NAFLD severity (p ≤ 0.05). The consumption of myristic acid was higher in patients with fibrosis (p = 0.02). Serum percentage and dietary consumption did not show correlations. Conclusion: Dietary consumption of bioactive fatty acids is different according to NAFLD severity. Individualized diets according to NAFLD severity could be successful in order to prevent liver injury-related outcomes. |
topic |
Body mass index Lipids Liver Nutrition NAFLD |
url |
http://www.sciencedirect.com/science/article/pii/S1665268120300697 |
work_keys_str_mv |
AT fabiolalopezbautista dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT varenkajbarberobecerra dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT mariayolandarios dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT mangelesramirezcisneros dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT cristellasanchezperez dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT marthahramosostos dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT misaeluribe dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT norbertocchaveztapia dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients AT evajuarezhernandez dietaryconsumptionandserumpatternofbioactivefattyacidsinnafldpatients |
_version_ |
1721388424736276480 |